Aeisha Rivers
Papers
4
Total Citations
90
H-Index
3
About
Dr. Aeisha Rivers is a pioneering radiation oncologist whose research focuses on optimizing stereotactic body radiation therapy (SBRT) for early-stage breast cancer. Her major contributions center on developing and refining a five-fraction stereotactic partial breast irradiation (S-PBI) protocol as a less invasive, more convenient alternative to traditional whole-breast radiation. Through a landmark Phase 1 dose-escalation trial—detailed in her most-cited paper (66 citations)—she demonstrated the safety and tolerability of this approach, paving the way for shorter, more targeted treatment courses. Her subsequent work, including a 2021 study (19 citations), rigorously evaluated cosmetic outcomes, showing that S-PBI preserves breast appearance while maintaining effective tumor control. Dr. Rivers’ research has been instrumental in advancing the clinical adoption of SBRT for breast cancer, reducing treatment from weeks to just five fractions. Her Phase 1 trials, presented at major oncology meetings, have established critical dose constraints and toxicity profiles that guide current practice. By balancing oncologic efficacy with quality of life, Dr. Rivers has made a lasting impact on breast cancer radiotherapy, offering patients a more convenient, well-tolerated option without compromising outcomes.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4